These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7712120

  • 1. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
    Laurent C, Bodeau-Péan S, Campion D, d'Amato T, Jay M, Dollfus S, Thibault F, Petit M, Samolyk D, Martinez M.
    Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
    [Abstract] [Full Text] [Related]

  • 2. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
    Tanaka T, Igarashi S, Onodera O, Tanaka H, Fukushima N, Takahashi M, Kameda K, Tsuji S, Ihda S.
    Am J Med Genet; 1996 Apr 09; 67(2):208-11. PubMed ID: 8723049
    [Abstract] [Full Text] [Related]

  • 3. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
    Crawford F, Hoyne J, Cai X, Osborne A, Poston D, Zaglul J, Dajani N, Walsh S, Bradley R, Solomon R, Mullan M.
    Am J Med Genet; 1996 Sep 20; 67(5):483-4. PubMed ID: 8886166
    [Abstract] [Full Text] [Related]

  • 4. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
    Chen CH, Chien SH, Hwu HG.
    Am J Med Genet; 1996 Jul 26; 67(4):418-20. PubMed ID: 8837714
    [Abstract] [Full Text] [Related]

  • 5. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
    Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1369-75. PubMed ID: 7902708
    [Abstract] [Full Text] [Related]

  • 6. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
    Verga M, Macciardi F, Pedrini S, Cohen S, Smeraldi E.
    Schizophr Res; 1997 May 24; 25(2):117-21. PubMed ID: 9187010
    [Abstract] [Full Text] [Related]

  • 7. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
    Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J, Howard A, Bean G, Joffe RT, Hudson CJ, Kennedy JL.
    Am J Med Genet; 1996 Jul 26; 67(4):415-7. PubMed ID: 8837713
    [Abstract] [Full Text] [Related]

  • 8. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
    Kaneshima M, Higa T, Nakamoto H, Nagamine M.
    Psychiatry Clin Neurosci; 1997 Dec 26; 51(6):379-81. PubMed ID: 9472122
    [Abstract] [Full Text] [Related]

  • 9. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
    Higuchi S, Muramatsu T, Murayama M, Hayashida M.
    Biochem Biophys Res Commun; 1994 Nov 15; 204(3):1199-205. PubMed ID: 7980596
    [Abstract] [Full Text] [Related]

  • 10. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R.
    Lancet; 1994 Apr 23; 343(8904):1045-6. PubMed ID: 7909081
    [No Abstract] [Full Text] [Related]

  • 11. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Asherson P, Williams N, Roberts E, McGuffin M, Owen M.
    Lancet; 1994 Apr 23; 343(8904):1045. PubMed ID: 7909080
    [No Abstract] [Full Text] [Related]

  • 12. Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.
    Harano M.
    Kurume Med J; 1997 Apr 23; 44(3):201-8. PubMed ID: 9339651
    [Abstract] [Full Text] [Related]

  • 13. Association of dopamine D2 receptor molecular variant with schizophrenia.
    Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M.
    Lancet; 1994 Mar 19; 343(8899):703-4. PubMed ID: 7907680
    [Abstract] [Full Text] [Related]

  • 14. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H.
    Lancet; 1994 Apr 23; 343(8904):1044. PubMed ID: 7909078
    [No Abstract] [Full Text] [Related]

  • 15. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
    Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, Sieghart WC, Meszaros K, Fathi N, Laurent C, Mallet J, Macciardi F, Pedrini S, Gill M, Hawi Z, Gibson S, Jazin EE, Yang HT, Adolfsson R, Pato CN, Dourado AM, Owen MJ.
    Am J Med Genet; 1998 Feb 07; 81(1):24-8. PubMed ID: 9514583
    [Abstract] [Full Text] [Related]

  • 16. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H.
    Psychiatry Clin Neurosci; 2002 Feb 07; 56(1):97-102. PubMed ID: 11929577
    [Abstract] [Full Text] [Related]

  • 17. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
    Itokawa M, Arinami T, Toru M.
    J Pharmacol Sci; 2010 Feb 07; 114(1):1-5. PubMed ID: 20716857
    [Abstract] [Full Text] [Related]

  • 18. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia.
    Serretti A, Macciardi F, Smeraldi E.
    Schizophr Res; 1998 Nov 30; 34(3):207-10. PubMed ID: 9850987
    [Abstract] [Full Text] [Related]

  • 19. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene.
    Craddock N, Roberts Q, Williams N, McGuffin P, Owen MJ.
    Psychiatr Genet; 1995 Nov 30; 5(2):63-5. PubMed ID: 7551964
    [Abstract] [Full Text] [Related]

  • 20. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Pal H, Saxena S.
    Natl Med J India; 1995 Nov 30; 8(3):125-6. PubMed ID: 7780354
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.